Global Premature Ejaculation Market 2014-2018: Key Vendors are Absorption, Furiex, Innovus and Plethora
M2 - Thu Oct 09, 4:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thdrgd/global_premature) has announced the addition of the "Global Premature Ejaculation Market 2014-2018" report to their offering. Premature ejaculation is a common sexual dysfunction in men, which is characterized by early discharge of semen. Premature ejaculation can be diagnosed through IELT, which is the average time taken by a man to ejaculate during sexual intercourse. There are two types of premature ejaculation: Primary premature ejaculation and secondary premature ejaculation. The analysts forecast the Global Premature Ejaculation market to grow at a CAGR of 10.20 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Premature Ejaculation market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of premature ejaculation that are available in the market. The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Premature Ejaculation market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market at large. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 06. Introduction 07. Disease Overview and Management 08. Market Landscape 09. Market Segmentation by Route of Administration 10. Market Segmentation by Dosage Form 11. Market Segmentation by Mechanism of Action 12. Geographical Segmentation 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Pipeline Portfolio 22. Key Vendor Analysis 23. Other Reports in this Series Companies Mentioned: - Absorption - Furiex - Innovus - Plethora - Bayer - Dong-A ST - Eli Lilly - Emcure - Endo - Futura Medical - GlaxoSmithKline - Medisyn - Menarini - NeuroHealing - Pfizer - Shionogi - Symyoo - Vectura - Vyrix For more information visit http://www.researchandmarkets.com/research/th..._premature
LLY: 70.16 (+0.42), GSK: 42.85 (+0.11)
Futura Medical plc - Product Pipeline Review - 2014
M2 - Thu Jul 24, 6:06AM CDT
Summary